Table 1

Genotypic and allelic frequencies of ANXA11 polymorphisms in controls and patients with sarcoidosis

VariableControls (n=418)Sarcoidosis (n=412)p Value*OR, 95% CI
NoPer centNoPer cent
rs27896790.0007
 TT11427.39422.80.1401.27, 0.93 to 1.74
 AT22553.818645.20.0121.42, 1.08 to 1.87
 AA7918.913232.00.00020.49, 0.36 to 0.68
Per A allele38345.845054.60.000041.42, 1.17 to 1.73
rs10495500.0002
 CC15436.820850.50.00070.57, 0.43 to 0.75
 CT19045.517041.30.2211.19, 0.90 to 1.56
 TT7417.7348.30.00082.39, 1.55 to 3.68
Per T allele33840.423828.80.0000020.61, 0.49 to 0.74
rs28199410.0002
 CC11427.39422.80.1411.27, 0.93 to 1.74
 CT22654.119046.10.0211.38, 1.05 to 1.81
 TT7818.712831.10.00040.51, 0.37 to 0.70
Per T allele38245.744654.10.00061.41, 1.16 to 1.71
  • *p Value was calculated by 2×3 and 2×2 χ2 tests based on codominant, dominant for the rare allele, heterosis and recessive for the rare allele models of inheritance.

  • α Value is adjusted by Bonferroni correction and statistically significant results (p<0.003).